Concepedia

Bas Pilzecker

BP

Statistics

Publications

6

Citations

563

H-Index

6

Active since

2016

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Bas Pilzecker is an author at The Netherlands Cancer Institute specializing in life sciences, molecular biology, and dna damage.

ORCID

Publications per year

2016–2022

6

Publications

6

CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness

Tomasz Ahrends, Aldo Spanjaard, Bas Pilzecker et al. · Immunity · 2017 · 399 citations · Full text

, , +17

PrimPol prevents APOBEC/AID family mediated DNA mutagenesis

Bas Pilzecker, Olimpia Alessandra Buoninfante, Colin E.J. Pritchard et al. · Nucleic Acids Research · 2016 · 66 citations · Full text

, , +17

DNA damage tolerance in hematopoietic stem and progenitor cells in mice

Bas Pilzecker, Olimpia Alessandra Buoninfante, Paul van den Berk et al. · Proceedings of the National Academy of Sciences · 2017 · 56 citations · Full text

, , +17

Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system

Olimpia Alessandra Buoninfante, Bas Pilzecker, Muhammad Assad Aslam et al. · Oncotarget · 2018 · 17 citations · Full text

, , +17

The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity

Luiza Sheyla Evenni Porfírio Will Castro, Wietske Pieters, Mir Farshid Alemdehy et al. · Frontiers in Pharmacology · 2021 · 13 citations · Full text

, , +17

1–5 of 6